Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

6.50
Delayed Data
As of Sep 30
 +0.20 / +3.17%
Today’s Change
3.22
Today|||52-Week Range
6.72
+30.52%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$718.9M

Company Description

Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff On May 13, 1998 by and is headquartered in Menlo Park, CA.

Contact Information

Corcept Therapeutics, Inc.
149 Commonwealth Drive
Menlo Park California 94025
P:(650) 327-3270
Investor Relations:
(650) 688-8783

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Joseph K. BelanoffPresident, Chief Executive Officer, Director & MD
Gary Charles RobbSecretary & Chief Financial Officer
Robert S. FishmanChief Medical Officer
Hazel HuntVice President-Research
Sean MaduckSenior Vice President-Commercial